Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2023 / Connectors and Interdisciplinarians / Koen Sandra

Koen Sandra

CEO and Co-owner, RIC group; Visiting Professor, Ghent University; Belgium

  • Profile

Meet Koen Sandra

A problem interdisciplinarians should tackle? As analytical scientists, we are a crucial piece in a bigger puzzle. At RIC, we’ve been involved in the development and authorization of various biotech drugs – and the route from discovery to approval is a perfect example of different disciplines and expertise joining forces to reach the ultimate goal of bringing life-changing treatment to patients.

Being active and knowledgeable in diverse application domains is beneficial for addressing complex analytical questions. Recent cases that fall into this category include the characterization of mRNA vaccines and gene therapy products – with knowledge of lipids, nucleic acid, proteins, and particle analysis is indispensable. Additionally, interdisciplinary work can help us solve problems related to correlation or particle formation in antibody formulations, poor bioreactor yields, and de-emulsification in vaccine productions. 

Another example includes the crucial interdisciplinary works during the unprecedented global pandemic that helped halt its spread. Despite the monumental challenge we were faced with, scientists faced this challenge head on. In our lab, we self-funded and developed an alternative diagnostic assay to address the scarcity of reagents. This applied use of mass spectrometry for SARS-COV2 detection was published with a significant number of authors and affiliations – showcasing the importance of collaborative work across fields. 

The secret to a successful interdisciplinary collaboration? “If you want to go fast, go alone. If you want to go far, go together.” One of our core values as a company is “stronger together” – we have no room for big ego’s. I still have to meet that multi-disciplinary know-how-to-do-it-all superhero. Even if that person did exist, humility is still the true key to success. Partnerships that lack trust and respect draw us away from our core values are doomed to fail.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.